ImmunityBio’s Soon-Shiong mischaracterized talks with FDA over cancer drug, sources say The company had expressed shock at the agency’s response to its submission

https://www.statnews.com/2026/01/29/immunitybio-soon-shiong-anktiva-bladder-cancer/ By Adam FeuersteinJan. 29, 2026 Senior Writer, Biotech